Breast Cancer
📧 Sign up to get email alerts when something new happens for Breast Cancer.
Sign up freeTop drugs studied for this disease
-
CLINICAL_TRIALS research · 2025-12-26Clinical Trial Update: A Single-arm, Prospective, Multi-center Cohort Study Based on Deep Learning-based cfDNA Fragment Omics to Verify the TuFEst Model for the Staging Diagnosis of Breast Cancer Lesions and Lymph Nodes
A multicenter, prospective single-arm cohort study to validate a deep learning-based cfDNA fragment omics approach (TuFEst model) for stagin…
-
CLINICAL_TRIALS research · 2025-12-26Clinical Trial Update: Clinical Study of SHR-A1811 With or Without Letrozole in Neoadjuvant Therapy for Early-Stage HR-Positive, HER2-Low Breast Cancer [Phase 2]
Phase 2 neoadjuvant study evaluating SHR-A1811 with or without letrozole in early-stage hormone receptor-positive, HER2-low breast cancer; c…
-
CLINICAL_TRIALS research · 2025-12-24Clinical Trial Update: Evaluating the Use of Patient Navigation to Promote Timely Diagnostic Evaluation During the COVID-19 Pandemic [NA]
This clinical trial evaluates whether patient navigation can promote timely diagnostic evaluation for breast cancer during the COVID-19 pand…
-
CLINICAL_TRIALS research · 2025-12-24Clinical Trial Update: RAGE Inhibition to Decrease Cardiotoxicity in Women With Early Breast Cancer [Phase 1, Phase 2]
A Phase 1/Phase 2 clinical trial evaluating a receptor for advanced glycation end products (RAGE) inhibitor to decrease cardiotoxicity in wo…
-
CLINICAL_TRIALS research · 2025-12-24Clinical Trial Update: Fulvestrant With Ribociclib Versus Physician's Choice Treatments Recurred After Completion of Adjuvant Cyclin-Dependent Kinase 4/6 Inhibitors in HR+, HER2- Metastatic Breast Cancer [Phase 2]
Phase 2 trial comparing fulvestrant plus ribociclib versus physician's choice treatments in HR-positive, HER2-negative metastatic breast can…
- Want full summaries, importance scores, and drug timelines? Upgrade to Plus or Pro.
-
CLINICAL_TRIALS research · 2025-12-24Clinical Trial Update: The Ohio State University (OSU) SCREEN Community Program [NA]
A recruiting clinical trial at Ohio State University's Comprehensive Cancer Center under the SCREEN Community Program, enrolling participant…
-
CLINICAL_TRIALS research · 2025-12-24Clinical Trial Update: THRIVE Well Cancer FDTN/Exercise_Creatine Supplementation [NA]
A clinical trial is recruiting to assess THRIVE Well Cancer FDTN/Exercise with creatine supplementation in breast cancer patients.
-
CLINICAL_TRIALS trial_result · 2025-12-24Clinical Trial Update: Developing and Evaluating Culturally Relevant Interventions to Improve Breast Cancer Screening [NA]
This clinical trial update notes the completion of a Johns Hopkins Bloomberg School of Public Health-led study evaluating culturally relevan…
-
CLINICAL_TRIALS trial_result · 2025-12-24Clinical Trial Update: A Safety Extension Study of Trastuzumab Emtansine in Participants Previously Treated With Trastuzumab Emtansine Alone or in Combination With Other Anti-Cancer Therapy in One of the Parent Studies [Phase 2]
This document provides an update on a Phase 2 safety extension trial of trastuzumab emtansine in patients previously treated with T-DM1, alo…
-
CLINICAL_TRIALS withdrawal · 2025-12-24Clinical Trial Update: Effect of Capivasertib on ctDNA in ER Positive Breast Cancer [Phase 2]
A Phase 2 trial evaluating capivasertib on circulating tumor DNA in estrogen receptor-positive breast cancer has been withdrawn.
-
CLINICAL_TRIALS research · 2025-12-24Clinical Trial Update: Interest of Circulating Tumor DNA in Digestive and Gynecologic/Breast Cancer [NA]
Ongoing clinical trial sponsored by Poitiers University Hospital evaluating circulating tumor DNA in breast, gynecologic, and digestive canc…
-
CLINICAL_TRIALS research · 2025-12-24Clinical Trial Update: Prospective Screening for Breast Cancer-related Lymphedema
Massachusetts General Hospital is conducting a prospective screening study to identify lymphedema associated with breast cancer treatment. T…
-
CLINICAL_TRIALS research · 2025-12-24Clinical Trial Update: Immune Response to Anti-HER2 Therapies in Patients With HER2-Positive Stage I-IV Breast Cancer
Ongoing recruitment for a study evaluating immune responses to anti-HER2 therapies in patients with HER2-positive breast cancer across stage…
-
CLINICAL_TRIALS research · 2025-12-24Clinical Trial Update: Real World Study of Biosimilar Trastuzumab in Her2 Positive Breast Cancer
Real-world study evaluating a biosimilar trastuzumab for breast cancer; the trial status is active but not recruiting.
-
CLINICAL_TRIALS research · 2025-12-24Clinical Trial Update: Prehabilitation of Breast Cancer-Related Lymphedema [NA]
Clinical trial update indicating the study on prehabilitation for breast cancer-related arm lymphedema has completed, with mentions of quali…
-
CLINICAL_TRIALS research · 2025-12-24Clinical Trial Update: Telemedicine-mHealth Symptom Cluster Intervention for Advanced Cancer Patients: Finding Our Center Under Stress (FOCUS) [NA]
This clinical trial update describes a telemedicine and mobile health symptom management intervention for advanced cancer patients (FOCUS), …
-
CLINICAL_TRIALS trial_result · 2025-12-23Clinical Trial Update: CLINICAL RESEARCH PROTOCOL [A Phase I, Single-arm, Open-label, Dose-escalation Clinical Study to Evaluate the Safety and Tolerability of Orialpha (BD-C) in Healthy Adult Volunteers] [Phase 1]
Phase I, single-arm, open-label dose-escalation study to evaluate the safety and tolerability of Orialpha (BD-C) in healthy adult volunteers…
-
CLINICAL_TRIALS research · 2025-12-23Clinical Trial Update: First-Line Sacituzumab Govitecan in Advanced Untreated Triple-Negative Breast Cancer Patients. [Phase 2]
A Phase 2 trial evaluating sacituzumab govitecan as first-line therapy in adults with advanced untreated triple-negative breast cancer; the …
-
CLINICAL_TRIALS trial_result · 2025-12-23Clinical Trial Update: A Study to Evaluate the Safety, Tolerability, Pharmacokinetics, Efficacy and Indications of RP903 [Phase 1]
Phase 1 study of RP903 conducted by Risen (Suzhou) Pharma Tech Co., Ltd. has completed, evaluating safety, tolerability, pharmacokinetics, e…
-
CLINICAL_TRIALS research · 2025-12-23Clinical Trial Update: Comparison of the Efficacy of Cryotherapy Combined With Compression in Preventing Neuropathy [NA]
A clinical trial evaluating whether cryotherapy combined with compression can prevent neuropathy in patients with non-metastatic breast canc…
-
CLINICAL_TRIALS research · 2025-12-23Clinical Trial Update: Patritumab Deruxtecan (U3-1402) in Unresectable Locally Advanced or Metastatic Breast Cancer [Phase 2]
A Phase 2 clinical trial update indicates Patritumab Deruxtecan (U3-1402) is being studied in unresectable locally advanced or metastatic br…
-
CLINICAL_TRIALS research · 2025-12-23Clinical Trial Update: A Study of A166 in Patients With HER2-Positive Unresectable or Metastatic Breast Cancer [Phase 2]
Phase 2 clinical trial update for A166 in patients with HER2-positive unresectable or metastatic breast cancer. The study is currently recru…
-
CLINICAL_TRIALS research · 2025-12-23Clinical Trial Update: Study Assessing QBS72S For Treating Brain Metastases [Phase 2]
Stanford University is conducting a Phase 2 trial of QBS72S for brain metastases. The study lists brain metastases, breast cancer, lung canc…
-
CLINICAL_TRIALS research · 2025-12-23Clinical Trial Update: An Exploratory Study of Pertuzumab and Trastuzumab in Combination With Palbociclib and Exemestane as Neoadjuvant Therapy for Triple-Positive Breast Cancer [Phase 2]
Phase 2 exploratory study evaluating Pertuzumab and Trastuzumab with Palbociclib and Exemestane as neoadjuvant therapy for triple-positive b…
-
CLINICAL_TRIALS research · 2025-12-23Clinical Trial Update: Study of Pembrolizumab and Mifepristone in Patients With Advanced HER2-negative Breast Cancer [Phase 2]
A Phase 2 trial of pembrolizumab in combination with mifepristone for advanced HER2-negative breast cancer has been terminated.